Limitations of CA125 as an index of peritoneal mesothelial cell mass: An in vitro study

Nephron - Clinical Practice

Volumn 100, Issue 2, 2005, Pages

  Brȩborowicz, Andrzej ^a   Brȩborowicz, Maciej ^a   Pyda, Malgorzata ^a   Połubinska, Alicja ^a   Oreopoulos, Dimitrios ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CA125; Cytokines; Glucose; Mesothelial cell mass

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 1BETA; MANNITOL; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

AGE DISTRIBUTION; ANTIGEN DETECTION; ARTICLE; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; HUMAN; HUMAN CELL; IN VIVO CULTURE; LONG TERM EXPOSURE; MESOTHELIOMA; MESOTHELIUM CELL; MONOLAYER CULTURE; PERITONEUM CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PERITONEAL CAVITY;

EID: 20944436635     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085032     Document Type: Article

References (24)

1. Bast RC, Xu FJ, Yu YH, Barnhili S, Zhang Z, Mills GB: CA125: The past and future. Int J Biol Markers 1998;13:179-187.
2. Zeimet AG, Marth C, Offner FA, Obrist P, Uhl-Steidl M, Feichtinger H, Stadlmann S, Daxenbichler G, Dapunt O: Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol 1996;62:384-389.
3. Visser CE, Brouwer-Steenbergen JJ, Betjes MG, Koomen GC, Beelen RH, Krediet RT: Cancer ant igen 125: A bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995;10:64-69.
4. Rippe B, Simonsen O, Heimburger O, Christensson A, Haraldsson B, Stelin G, Weiss L, Nielsen FD, Bro S, Friedberg M, Wieslander A: Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001;59:348-357.
5. Jones S, Holmes CJ, Krediet RT, Mackenzie R, Faict D, Traneaus A: Continuous dialysis with bicarbonate/lactate based peritoneal dialysis solution is associated with an increase in dialysate CA125 and a decrease in hyaluronic acid (HA) levels. Kidney Int 2001;59:1529-1538.
6. Krediet RT: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001;21:560-567.
7. Sanusi AA, Zweers MM, Weening JJ, de Waart DR, Struijk DG, Krediet RT: Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis. Perit Dial Int 2001;21:495-500.
8. Jimenez C, Diaz C, Selgas R, Auxiliadora Bajo M, del Peso G, Sanchez-Tomero JA, Gonzalez-Gancedo P: Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: The relationship with peritoneal outcome. Adv Perit Dial 1999;15:36-39.
9. Pannekeet MM, Zemel D, Koomen GC, Straijk DG, Krediet RT: Dialysate markers of peritoneal tissue during peritonitis in stable CAPD. Perit Dial Int 1995;15:217-225.
10. Camera A, Villa MR, Rocco S, De Novellis T, Costantini S, Pezzullo L, Lucania A, Mariano A, Macchia V, Rotoli B: Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement. Cancer 2000;88:75-78.
11. Moore E, Soper DE: Clinical utility of CA125 levels in predicting laparoscopically confirmed salpingitis in patients with clinically diagnosed pelvic inflammatory disease. Infect Dis Obstet Gynecol 1998;6:182-185.
12. Carpenter PM, Gamboa GP, Dorion GE, Ramsinghani NS, Aissi A, Manetta A: Radiation-induced CA125 production by mesothelial cells. Gynecol Oncol 1996;63:328-332.
13. Deschenes M, Michel RP, Alpert E, Barkun JS, Metrakos P, Tchervenkov J: Elevation of CA125 level is due to abdominal distention in liver transplantation candidates. Transplantation 2002;72:1519-1522.
14. BrȨ borowicz A, Rodela H, Oreopoulos DG: Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992;41:1280-1285.
15. Pannekeet MM, Koomen GC, Struijk DG, Krediet RT: Dialysate CA125 in stable CAPD patients: No relation with transport parameters. Clin Nephrol 1995;44:248-254.
16. Lai KN, Lai KB, Szeto CC, Ho KK, Poon P, Lam CW, Leung JC: Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: Their relationship with transport parameters. Am J Kidney Dis 1997;29:699-705.
17. Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, Rose-John S, Fuller GM, Topley N, Jones SA: IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001;14:705-714.
18. Zeillemaker AM, Verbrugh HA, Hoynck van Papendrecht AA, Leguit P: CA125 secretion by peritoneal mesothelial cells. J Clin Pathol 1994;47:263-265.
19. Zeimet AG, Offner FA, Marth C, Heim K, Feichtinger H, Daxenbichler G, Dapunt O: Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial cells and ovarian cancer cells. Anticancer Res 1997;17:3129-3131.
20. Zeimet AG, Offner FA, Müller-Holzner E, Widschwendter M, Abendstein B, Fuith LC, Daxenbichler G, Marth C: Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125. Tumour Biol 1998;19:275-282.
21. Kawanishi H, Moriishi M, Harada Y, Sakikubo E, Nagai T, Tsuchiya S: Necessity of correcting cancer antigen 125 appearance rates by body surface area. Adv Perit Dial 2000;16:22-25.
22. Passadakis P, Panagoutsos S, Thodis E, Tsivara I, Sopassi F, Kartali S, Vargemezis V: Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 1999;15:40-44.
23. BrȨ borowicz A, BrȨ borowicz M, Oreopoulos DG: Glucose-induced changes in the phenotype of human peritoneal mesothelial cells: Effect of L-2-oxothiazolidine carboxylic acid. Am J Nephrol 2003;23:471-476.
24. Wong TY, Phillips AO, Witowski J, Topley N: Glucose-mediated induction of TGF-β and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003;63:1404-1416.